C07D 473 - Heterocyclic compounds containing purine ring systems

Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
02/2000
02/03/2000	DE19834044A1 Neue substituierte Pyrazolderivate New substituted pyrazole derivatives
02/02/2000	EP0976751A1 A process for the isomerisation of an N-7 isomer into an N-9 isomer useful in the synthesis of acyclic nucleosides
02/02/2000	EP0976750A1 Novel z-valacyclovir crystals
02/01/2000	US6020339 Aryl furan derivatives as PDE IV inhibitors
02/01/2000	US6020337 Electronegative-substituted long chain xanthine compounds
01/2000
01/26/2000	EP0973521A1 Cyclopentylxanthine derivatives for use in the treatment of cystic fibrosis
01/26/2000	CN1242373A Novel arabinosyladenine derivatives
01/25/2000	US6017923 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents
01/20/2000	WO2000002870A1 Antiviral macrocyclic compounds
01/19/2000	EP0971923A2 Synthesis of acyclic nucleoside derivatives
01/19/2000	CN1048493C O6-substituted guanine derivatives, a process for their prepn. and their use
01/18/2000	US6015827 Benzoxazole-4-carboxamides and their use in inhibiting poly (adp-ribose) polymerase activity and improving cytotoxic effectiveness of cytotoxic drugs or radiotherapy
01/12/2000	EP0970082A2 Biazacyclic crf antagonists
01/12/2000	EP0970081A1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
01/12/2000	EP0970078A1 Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides
01/12/2000	EP0970074A1 METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH $g(b)-CONFIGURATION
01/12/2000	EP0969843A2 Antitussive compositions
01/11/2000	CA2180754C Heteroaryl-substituted deoxy glycero-phosphoethanolamines
01/06/2000	WO2000000491A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents
01/06/2000	CA2335595A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents
01/05/2000	EP0539420B1 substituted thiazolyl and substituted pyridinyl derivatives
01/04/2000	US6011029 Benzodiazepine compounds
12/1999
12/29/1999	WO1999067262A1 Adenosine derivatives
12/29/1999	EP0967220A1 Novel arabinosyladenine derivatives
12/29/1999	EP0967213A1 Process for preparing tetraalkylammonium salt of 6-halogenopurine derivative
12/29/1999	EP0966467A1 Annulated azole derivatives useful as microbicidal agents
12/29/1999	EP0654031B1 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
12/23/1999	WO1999065896A1 Preparation of heteroaryl compounds
12/23/1999	CA2334677A1 Preparation of heteroaryl compounds
12/22/1999	EP0684953A4 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives.
12/21/1999	US6005109 Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
12/21/1999	US6004966 Use of xanthine oxidase inhibitors as anti-ischaemic agents
12/16/1999	WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999	WO1999064051A1 Novel antibacterial compounds
12/16/1999	WO1999064049A1 Novel antibacterial agents
12/16/1999	WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999	WO1999064047A1 Novel antiviral compounds
12/16/1999	WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999	WO1999063994A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
12/16/1999	WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999	WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999	WO1999063939A2 Multibinding inhibitors of cyclooxygenase-2
12/16/1999	WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999	WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2321274A1 Novel antiviral compounds
12/16/1999	CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999	CA2321162A1 Novel antibacterial compounds
12/16/1999	CA2320290A1 Multibinding inhibitors of cyclooxygenase-2
12/16/1999	CA2320241A1 Multivalent macrolide antibiotics
12/16/1999	CA2319761A1 Multibinding inhibitors of hmg-coa reductase
12/16/1999	CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999	CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999	CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999	CA2316999A1 Inhibitors of hiv reverse transcriptase
12/15/1999	EP0725782B1 A 1 adenosine receptor agonists and antiagonists
12/14/1999	US6001841 Cyclobutyl oligonucleotide surrogates
12/09/1999	WO1999062905A1 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
12/07/1999	US5998456 Benzimidazole compounds containing 1,2,4-triazole ring, and compositions and methods of use containing the same
12/07/1999	US5998387 Method for using A1 adenosine receptor agonists
12/07/1999	CA2012686C Treatment and compounds
12/01/1999	EP0960884A1 Process for the production of 3,7-dialkylxanthins from 3-alkylxanthins
11/1999
11/30/1999	US5994541 Process for producing 2-amino-6-iodopurine
11/30/1999	US5994361 Antitumor, anticancer agent
11/30/1999	US5994038 Support with silver halide emulsion and a 3-indoloylacetanilide coupler
11/25/1999	WO1999050249A3 Pyrimidines and triazines as integrin antagonists
11/25/1999	WO1999036429A3 Nucleobase oligomers
11/24/1999	EP0958821A1 Fat emulsion containing xanthine derivative
11/24/1999	EP0957913A1 N-linked sulfonamides of heterocyclic thioesters
11/24/1999	CN1236318A Method for treating bronchitis with uridine triphosphates and related compounds
11/24/1999	CN1046728C Cyclopropane derivatives and method of preparing the same
11/24/1999	CN1046720C Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
11/23/1999	US5990118 Purine compounds and xanthine oxidase inhibitors
11/17/1999	EP0956855A1 Immunosuppressive effects of 8-substituted xanthine derivatives
11/17/1999	EP0956297A1 Chiral peptide nucleic acids
11/17/1999	CN1235594A Methods and compositions for lipidization of hydrophilic molecules
11/16/1999	US5986053 Peptide nucleic acids complexes of two peptide nucleic acid strands and one nucleic acid strand
11/11/1999	WO1999057120A1 Novel serotonin-like 9-substituted hypoxanthine and methods of use
11/11/1999	WO1999057119A1 Novel dopamine-like 9-substituted hypoxanthine and methods of use
11/11/1999	WO1999057103A1 Condensed imidazole derivative and therapeutic agent for liver disease
11/10/1999	EP0766691B1 Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
11/10/1999	EP0662961B1 Process of synthesizing useful intermediates of substituted imidazole compounds
11/09/1999	US5981535 Substituted xanthines and their use in the treatment of cerebrovascular disorders and other diseases
11/09/1999	US5981525 Indole derivatives useful in the treatment of osteoporosis
11/09/1999	US5981524 Substituted 9-alkyladenines
11/09/1999	US5981492 Substituted 5-membered ring heterocycles, their preparation and their use
11/03/1999	EP0953870A1 Photographic element containing acetamido DIR coupler
11/02/1999	US5977169 Substituted tetronic acids useful for treating HIV and other retroviruses
11/02/1999	US5977119 Trisubstituted thioxanthines
11/02/1999	US5977061 Viricide against dna viruses
10/1999
10/28/1999	WO1999054331A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/28/1999	CA2328264A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/27/1999	CN1045963C Preparation of purines
10/26/1999	US5973161 Catalytic cyclizing corresponding linear compound in a organic solvent at a temperature between about-78 degrees c and about 150 degrees c
10/26/1999	US5972982 Containing 5-to 9-membered heteroaryl mono- or bicyclic ring system having no more than 1 carbonyl carbon in the ring system; viricides, bactericides
10/21/1999	WO1999043676A3 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines

1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 120